Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jin-cheng Lu & Mei-juan Li. (2022) Optimisation analysis of resource allocation for China’s high-tech industry based on an extended inverse DEA with frontier changes. Technology Analysis & Strategic Management 0:0, pages 1-18.
Read now
Read now
Articles from other publishers (16)
Chao Lu & Bin Li. (2023) The influence factors of innovation networking formation based on ERGM: Evidence from the smart medical industry. Journal of Digital Economy 2, pages 64-80.
Crossref
Crossref
Wenwen Zheng, Junjun Li, Yu Wang, Zhuyifan Ye, Hao Zhong, Hung Wan Kot, Defang Ouyang & Ging Chan. (2023) Quantitative Analysis for Chinese and US-listed Pharmaceutical
Companies by the LightGBM Algorithm. Current Computer-Aided Drug Design 19:6, pages 405-415.
Crossref
Crossref
Teresa García-Valderrama, Jaime Sanchez-Ortiz & Eva Mulero-Mendigorri. (2023) Knowledge production and commercialization from R&D: the pharmaceutical sector. Management Decision 61:13, pages 222-247.
Crossref
Crossref
Ceren Erdin & Mehmet Çağlar. (2022) National innovation efficiency: a DEA-based measurement of OECD countries. International Journal of Innovation Science 15:3, pages 427-456.
Crossref
Crossref
Svetlana V. Ratner, Artem M. Shaposhnikov & Andrey V. Lychev. (2023) Network DEA and Its Applications (2017–2022): A Systematic Literature Review. Mathematics 11:9, pages 2141.
Crossref
Crossref
Jung Youn Mo. (2023) Environmental policy and R&D productivity: A case study from the Korean Emissions Trading Scheme. Science and Public Policy 50:1, pages 120-128.
Crossref
Crossref
Fang Chen Kao & Minh‐Hieu Le. (2022) Effects of corporate social responsibility on pharmaceutical multinational enterprises performance: Research and development and business efficiency perspectives. Managerial and Decision Economics 43:8, pages 3419-3434.
Crossref
Crossref
Shen Zhong, Shuqi Liang, Yuxin Zhong, Yunying Zheng & Fengjun Wang. (2022) Measure on innovation efficiency of China's pharmaceutical manufacturing industry. Frontiers in Public Health 10.
Crossref
Crossref
Xueling Guan, Lijiang Chen, Qing Xia & Zhaohui Qin. (2022) Innovation Efficiency of Chinese Pharmaceutical Manufacturing Industry from the Perspective of Innovation Ecosystem. Sustainability 14:20, pages 12993.
Crossref
Crossref
Xiu-juan Huang, Ran An, Ming-Miin Yu & Fang-fang He. (2022) Tourism efficiency decomposition and assessment of forest parks in China using dynamic network data envelopment analysis. Journal of Cleaner Production 363, pages 132405.
Crossref
Crossref
Minh-Hieu Le & Wen-Min Lu. (2022) An integrated multiple objective decision making approach for exploring the competitiveness of pharmaceutical multinational enterprises. Annals of Operations Research.
Crossref
Crossref
Liping Fu, Shan Zhang & Fan Wu. (2022) The Impact of Compensation Gap on Corporate Innovation: Evidence from China’s Pharmaceutical Industry. International Journal of Environmental Research and Public Health 19:3, pages 1756.
Crossref
Crossref
Jinfa Li, Ruijie Qin & Hongbing Jiang. (2022) Measurement of Innovation Efficiency in China’s Electronics and Communication Equipment Manufacturing Industry-Based on Dynamic Network SBM Model. Sustainability 14:3, pages 1227.
Crossref
Crossref
Ebenezer Fiifi Emire Atta Mills, Kailin Zeng, Liu Fangbiao & Li Fangyan. (2021) Modeling innovation efficiency, its micro-level drivers, and its impact on stock returns. Chaos, Solitons & Fractals 152, pages 111303.
Crossref
Crossref
Ioannis E. Tsolas. (2021) Firm Credit Scoring: A Series Two-Stage DEA Bootstrapped Approach. Journal of Risk and Financial Management 14:5, pages 214.
Crossref
Crossref
Azin Karami, Hadi Shirouyehzad & Milad Asadpour. (2021) A DEA-Based Decision Support Framework for Organizations’ Performance Evaluation considering TQM and Knowledge Management. Journal of Healthcare Engineering 2021, pages 1-13.
Crossref
Crossref